NDRA vs FLGT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
FLGT Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Fulgent Genetics, Inc. Common Stock (FLGT) driven by superior Valuation, Momentum & Technical, Options & Structure while NDRA counters with relative strength in Growth & Margin. Fundamentally, NDRA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus FLGT at 7.7x Forward P/E and -37.1% operating margin (+7.5% YoY). In options structure, NDRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against FLGT sits in BREAKOUT (13th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NDRA Revenue | FLGT Revenue | NDRA Op. Margin | FLGT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | $20M | -146080.5% | -23.7% | FLGT |
| FY2019 | N/A | $30M | N/A | -1.3% | FLGT |
| FY2020 | N/A | $420M | N/A | 68.8% | FLGT |
| FY2021 | N/A | $990M | N/A | 68.1% | FLGT |
| FY2022 | N/A | $620M | N/A | 28.8% | FLGT |
| FY2023 | N/A | $290M | N/A | -67.6% | FLGT |
| FY2024 | N/A | $280M | N/A | -26.1% | FLGT |
| FY2025 | N/A | $320M | N/A | -28.2% | FLGT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NDRA | FLGT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.6M | $689.0M | Larger Scale | FLGT |
| Trailing P/E Ratio Valuation | N/M | 7.7x | Lower Multiple | FLGT |
| Forward P/E Ratio Valuation | N/M | 7.7x | Lower Multiple | FLGT |
| Revenue Growth (YoY) Growth | +0.0% | +7.5% | Higher Growth | FLGT |
| Operating Margin (TTM) Profitability | 0.0% | -37.1% | Higher Margin | NDRA |
| Net Profit Margin Profitability | 0.0% | -27.5% | Higher Margin | NDRA |
| Return on Equity (ROE) Capital Efficiency | -152.0% | -8.7% | Higher ROE | FLGT |
| 52-Week Range Position Momentum | 37% ($3โ$7) | 60% ($13โ$31) | Stronger Trend | FLGT |
| Beta / 30D Volatility Risk Regime | 0.71ฮฒ ยท 48% Vol | 1.10ฮฒ ยท 110% Vol | Lower Realized Risk | NDRA |
| Unified Institutional Score Composite Signal | 44.7 / 100 (HOLD) | 33.3 / 100 (SELL) | Higher Composite | NDRA |